Alpine Immune Sciences’ (ALPN) Outperform Rating Reiterated at Wedbush
Wedbush reiterated their outperform rating on shares of Alpine Immune Sciences (NASDAQ:ALPN – Free Report) in a research note released on Wednesday, Marketbeat reports. They currently have a $26.00 target price on the biotechnology company’s stock. Wedbush also issued estimates for Alpine Immune Sciences’ FY2023 earnings at ($0.96) EPS, Q2 2024 earnings at ($0.20) EPS, […]
More Stories
Short Interest in Qube Holdings Limited (OTCMKTS:QUBHF) Expands By 17.6%
Qube Holdings Limited (OTCMKTS:QUBHF – Get Free Report) was the target of a significant increase in short interest in October....
Mycronic AB (publ) (OTCMKTS:MICLF) Short Interest Up 16.4% in October
Mycronic AB (publ) (OTCMKTS:MICLF – Get Free Report) was the recipient of a large increase in short interest during the...
Short Interest in Nemak, S. A. B. de C. V. (OTCMKTS:NMAKF) Rises By 21.6%
Nemak, S. A. B. de C. V. (OTCMKTS:NMAKF – Get Free Report) was the recipient of a significant increase in...
Short Interest in Green Thumb Industries Inc. (OTCMKTS:GTBIF) Drops By 21.3%
Green Thumb Industries Inc. (OTCMKTS:GTBIF – Get Free Report) was the target of a large decline in short interest in...
Genmab A/S (NASDAQ:GMAB) Short Interest Up 23.2% in October
Genmab A/S (NASDAQ:GMAB – Get Free Report) was the target of a significant increase in short interest during the month...
Short Interest in Invesco Dorsey Wright Basic Materials Momentum ETF (NASDAQ:PYZ) Decreases By 25.0%
Invesco Dorsey Wright Basic Materials Momentum ETF (NASDAQ:PYZ – Get Free Report) was the recipient of a significant decrease in...